Compounds > vancomycin
Page last updated: 2024-08-21

vancomycin and quinupristin

vancomycin has been researched along with quinupristin in 23 studies

Research

Studies (23)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's7 (30.43)18.2507
2000's15 (65.22)29.6817
2010's1 (4.35)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Huneycutt, S; Phillips, A; Tush, GM; Ward, JD1
Aeschlimann, JR; Rybak, MJ1
Klare, I; Werner, G; Witte, W1
Cohen, MA; Huband, MD1
Brown, GH; Rotschafer, JC; Wright, DH1
Bompart, F; Hachem, R; Raad, I1
Andrews, J; Ashby, J; Jevons, G; Lines, N; Wise, R1
Grucz, RG; Hershberger, E; Moldovan, T; Rybak, MJ1
Lundstrom, TS; Sobel, JD1
Flanagan, PG; Penrose-Stevens, A; Pitman, I; Simpson, BA; Tan, TY1
Foustoukou, M; Ioannidou, S; Kotsovili-Tseleni, A; Legakis, NJ; Tassios, PT; Vatopoulos, A1
Ameur, N; Bléton, R; Crémieux, AC; Feger, C; Ismael, F; Lemaitre, F; Massias, L; Muller-Serieys, C; Saleh-Mghir, A1
Rigoli, R; Scotton, PG; Vaglia, A1
Citron, DM; Fernandez, HT; Goldstein, EJ; Merriam, CV; Tyrrell, KL; Warren, YA1
Agamah, E; Goodrich, J; Kanchanapoom, T; Khardori, N; Koirala, J1
Fougnot, S; Lozniewski, A; Mory, F; Rabaud, C; Schuhmacher, H1
Fraser, TG; Hansen, C; Long, JK1
Chaudhury, A; Kumar, AG1
Manfredi, R1
De Vecchi, E; Drago, L; Nicola, L1
Manzur, A; Pujol, M; Suárez, C; Tubau, F1
Ermertcan, S; Gülden, E1
Biavasco, F; Citterio, B; Mangiaterra, G; Pasquaroli, S; Vignaroli, C1

Reviews

4 review(s) available for vancomycin and quinupristin

ArticleYear
Gram-positive infections: pharmacy issues and strategy for quinupristin/dalfopristin.
    Diagnostic microbiology and infectious disease, 1999, Volume: 33, Issue:2

    Topics: Anti-Bacterial Agents; Humans; Vancomycin; Virginiamycin

1999
Antibiotics for gram-positive bacterial infections. Vancomycin, teicoplanin, quinupristin/dalfopristin, and linezolid.
    Infectious disease clinics of North America, 2000, Volume: 14, Issue:2

    Topics: Acetamides; Anti-Bacterial Agents; Drug Resistance, Microbial; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Linezolid; Oxazoles; Oxazolidinones; Teicoplanin; Vancomycin; Virginiamycin

2000
Newer antibiotics for serious gram-positive infections.
    Cleveland Clinic journal of medicine, 2006, Volume: 73, Issue:9

    Topics: Acute Disease; Adolescent; Anti-Bacterial Agents; Daptomycin; Drug Resistance, Bacterial; Female; Gram-Positive Bacterial Infections; Humans; Middle Aged; Vancomycin; Virginiamycin

2006
[Therapeutic perspectives of linezolid in the management of infections due to multiresistant Gram-positive pathogens].
    Recenti progressi in medicina, 2007, Volume: 98, Issue:3

    Topics: Acetamides; Administration, Oral; Anti-Infective Agents; Daptomycin; Drug Resistance, Multiple, Bacterial; Enterococcus; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Injections, Intravenous; Linezolid; Microbial Sensitivity Tests; Minocycline; Oxazolidinones; Practice Guidelines as Topic; Staphylococcus aureus; Streptococcus pneumoniae; Teicoplanin; Tigecycline; Time Factors; Vancomycin; Virginiamycin

2007

Trials

1 trial(s) available for vancomycin and quinupristin

ArticleYear
Prospective, randomized dose-ranging open phase II pilot study of quinupristin/dalfopristin versus vancomycin in the treatment of catheter-related staphylococcal bacteremia.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1999, Volume: 18, Issue:3

    Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Catheterization; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Pilot Projects; Prospective Studies; Single-Blind Method; Staphylococcal Infections; Vancomycin; Virginiamycin

1999

Other Studies

18 other study(ies) available for vancomycin and quinupristin

ArticleYear
Intraventricular quinupristin/dalfopristin for the treatment of vancomycin-resistant Enterococcus faecium shunt infection.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1998, Volume: 26, Issue:6

    Topics: Adult; Anti-Bacterial Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Injections, Intraventricular; Male; Vancomycin; Ventriculoperitoneal Shunt; Virginiamycin

1998
Pharmacodynamic analysis of the activity of quinupristin-dalfopristin against vancomycin-resistant Enterococcus faecium with differing MBCs via time-kill-curve and postantibiotic effect methods.
    Antimicrobial agents and chemotherapy, 1998, Volume: 42, Issue:9

    Topics: Drug Resistance, Microbial; Drug Therapy, Combination; Enterococcus faecium; Microbial Sensitivity Tests; Vancomycin; Virginiamycin

1998
Association between quinupristin/dalfopristin resistance in glycopeptide-resistant Enterococcus faecium and the use of additives in animal feed.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1998, Volume: 17, Issue:6

    Topics: Animal Feed; Animals; Anti-Bacterial Agents; Drug Resistance, Microbial; Drug Resistance, Multiple; Enterococcus faecium; Food Additives; Meat; Meat Products; Vancomycin; Virginiamycin

1998
Activity of clinafloxacin, trovafloxacin, quinupristin/dalfopristin, and other antimicrobial agents versus Staphylococcus aureus isolates with reduced susceptibility to vancomycin.
    Diagnostic microbiology and infectious disease, 1999, Volume: 33, Issue:1

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Naphthyridines; Staphylococcus aureus; Vancomycin; Virginiamycin

1999
Antimicrobial resistance in gram-positive pathogens isolated in the UK between October 1996 and January 1997.
    The Journal of antimicrobial chemotherapy, 1999, Volume: 43, Issue:5

    Topics: Anti-Bacterial Agents; Cross Infection; Drug Resistance, Microbial; Enterococcus faecium; Environmental Monitoring; Gram-Positive Bacteria; Hospitals; Humans; Microbial Sensitivity Tests; Staphylococcus; Streptococcus pneumoniae; United Kingdom; Vancomycin; Virginiamycin

1999
In vitro activities of daptomycin, vancomycin, linezolid, and quinupristin-dalfopristin against Staphylococci and Enterococci, including vancomycin- intermediate and -resistant strains.
    Antimicrobial agents and chemotherapy, 2000, Volume: 44, Issue:4

    Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Drug Resistance, Multiple; Enterococcus; Linezolid; Microbial Sensitivity Tests; Oxazoles; Oxazolidinones; Staphylococcus; Time Factors; Vancomycin; Virginiamycin

2000
Treatment of a vancomycin-resistant Enterococcus faecium ventricular drain infection with quinupristin/dalfopristin and review of the literature.
    The Journal of infection, 2000, Volume: 41, Issue:1

    Topics: Acetamides; Anti-Bacterial Agents; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Enterococcus faecium; Fatal Outcome; Female; Gram-Positive Bacterial Infections; Humans; Hydrocephalus; Injections, Intravenous; Injections, Intraventricular; Injections, Spinal; Linezolid; Middle Aged; Oxazoles; Oxazolidinones; Subarachnoid Hemorrhage; Tomography, X-Ray Computed; Vancomycin; Ventriculoperitoneal Shunt; Virginiamycin

2000
Antibiotic resistance rates and macrolide resistance phenotypes of viridans group streptococci from the oropharynx of healthy Greek children.
    International journal of antimicrobial agents, 2001, Volume: 17, Issue:3

    Topics: Adolescent; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Child; Child, Preschool; Clarithromycin; Clindamycin; Drug Resistance, Microbial; Erythromycin; Female; Fluoroquinolones; Greece; Humans; Infant; Male; Microbial Sensitivity Tests; Oropharynx; Phenotype; Rifampin; Streptococcus; Tetracycline; Vancomycin; Virginiamycin

2001
Combination of quinupristin-dalfopristin (Synercid) and rifampin is highly synergistic in experimental Staphylococcus aureus joint prosthesis infection.
    Antimicrobial agents and chemotherapy, 2002, Volume: 46, Issue:4

    Topics: Animals; Anti-Bacterial Agents; Antibiotics, Antitubercular; Drug Synergism; Drug Therapy, Combination; Joint Prosthesis; Methicillin Resistance; Prosthesis-Related Infections; Rabbits; Rifampin; Staphylococcal Infections; Tissue Distribution; Vancomycin; Virginiamycin

2002
Combination of quinupristin/dalfopristin and glycopeptide in severe methicillin-resistant staphylococcal infections failing previous glycopeptide regimens.
    Infection, 2002, Volume: 30, Issue:3

    Topics: Adult; Aged; Anti-Bacterial Agents; Colony Count, Microbial; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Methicillin Resistance; Microbial Sensitivity Tests; Sampling Studies; Sensitivity and Specificity; Severity of Illness Index; Staphylococcal Infections; Teicoplanin; Treatment Outcome; Vancomycin; Virginiamycin

2002
In vitro activities of daptomycin, vancomycin, quinupristin- dalfopristin, linezolid, and five other antimicrobials against 307 gram-positive anaerobic and 31 Corynebacterium clinical isolates.
    Antimicrobial agents and chemotherapy, 2003, Volume: 47, Issue:1

    Topics: Acetamides; Anti-Bacterial Agents; Corynebacterium; Daptomycin; Gram-Positive Bacteria; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Vancomycin; Virginiamycin

2003
Treatment of central nervous system infection by vancomycin-resistant enterococcus faecium.
    Diagnostic microbiology and infectious disease, 2003, Volume: 45, Issue:3

    Topics: Aged; Brain Neoplasms; Central Nervous System Infections; Drug Resistance, Bacterial; Drug Therapy, Combination; Enterococcus faecium; Follow-Up Studies; Gram-Positive Bacterial Infections; Humans; Injections, Intralesional; Lymphoma; Male; Opportunistic Infections; Risk Assessment; Treatment Outcome; Vancomycin; Virginiamycin

2003
In vitro activities of cefotaxime, vancomycin, quinupristin/dalfopristin, linezolid and other antibiotics alone and in combination against Propionibacterium acnes isolates from central nervous system infections.
    The Journal of antimicrobial chemotherapy, 2005, Volume: 55, Issue:2

    Topics: Acetamides; Cefotaxime; Central Nervous System Infections; Drug Therapy, Combination; Gram-Positive Bacterial Infections; Humans; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Propionibacterium acnes; Vancomycin; Virginiamycin

2005
In vitro activity of antimicrobial agents against oxacillin resistant staphylococci with special reference to Staphylococcus haemolyticus.
    Indian journal of medical microbiology, 2007, Volume: 25, Issue:1

    Topics: Acetamides; Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; India; Linezolid; Microbial Sensitivity Tests; Oxacillin; Oxazolidinones; Staphylococcus; Staphylococcus haemolyticus; Teicoplanin; Vancomycin; Virginiamycin

2007
A comparative in-vitro evaluation of resistance selection after exposure to teicoplanin, vancomycin, linezolid and quinupristin-dalfopristin in Staphylococcus aureus and Enterococcus spp.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2008, Volume: 14, Issue:6

    Topics: Acetamides; Anti-Bacterial Agents; Colony Count, Microbial; Drug Resistance, Bacterial; Enterococcus faecalis; Enterococcus faecium; Linezolid; Methicillin Resistance; Microbial Sensitivity Tests; Mutation; Oxazolidinones; Selection, Genetic; Staphylococcus aureus; Teicoplanin; Vancomycin; Virginiamycin

2008
[Persistent bacteremia caused by methicillin-resistant Staphylococcus aureus].
    Enfermedades infecciosas y microbiologia clinica, 2008, Volume: 26, Issue:9

    Topics: Aged; Bacteremia; Catheterization, Central Venous; Chronic Disease; Daptomycin; Discitis; Humans; Jugular Veins; Male; Methicillin-Resistant Staphylococcus aureus; Pancreatitis; Rifampin; Staphylococcal Infections; Vancomycin; Virginiamycin

2008
[In vitro activities of quinupristin/dalfopristin in combination with vancomycin and gatifloxacin against Staphylococcus aureus and Enterococcus faecium clinical isolates].
    Mikrobiyoloji bulteni, 2009, Volume: 43, Issue:1

    Topics: Anti-Bacterial Agents; Drug Combinations; Drug Synergism; Enterococcus faecium; Fluoroquinolones; Gatifloxacin; Humans; Staphylococcus aureus; Vancomycin; Virginiamycin

2009
Influence of sublethal concentrations of vancomycin and quinupristin/dalfopristin on the persistence of viable but non-culturable Staphylococcus aureus growing in biofilms.
    The Journal of antimicrobial chemotherapy, 2018, 12-01, Volume: 73, Issue:12

    Topics: Anti-Bacterial Agents; Bacterial Load; Biofilms; Gene Expression Profiling; Microbial Viability; Staphylococcus aureus; Vancomycin; Virginiamycin

2018